Cambridge BioMarketing Discusses Outlook for Gene Therapy and CAR-T Treatments in 2018Business Wire (press release)It will be more important than ever for healthcare companies to incorporate the hyperpersonalized experience in marketing and communicati… Continue reading
WKYC-TV |
Immunotherapy closing in on a cure for cancer
WKYC-TV The immunotherapy trials are taking place in select cities across the United States, but people who live in Kentuckiana don’t have to travel far to get on the list. It’s happening right now at the James Graham Brown Cancer Center. James Long has spent … |
The Scientist |
Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
The Scientist Originally developed by Kite Pharma—a California-based startup that was bought by Gilead for nearly $12 billion in cash earlier this year—Yescarta is just the second CAR T-cell therapy to be approved in the U.S. Doctors at the 15 cancer hospitals … |
FierceBiotech |
Regeneron pairs PD-1 latecomer with ISA’s HPV immunotherapy
FierceBiotech … cancers like cervical and head-and-neck cancer, say the two companies. The Leiden-based company’s immunotherapy is aimed at HPV16, a strain of the virus that is thought to be responsible for 55% of human cervical cancers and premalignant lesions … Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology CollaborationMarkets Insider Dutch and US Biotechs Team Up Against HPV-related CancerLabiotech.eu (blog) Regeneron teams up with ISA Pharma to develop immunotherapeutic targeting HPV16-induced cancerSeeking Alpha |
Genetic Engineering & Biotechnology News |
Mature Cell Discovery Could Cause a Rethink on the Origins of Cancer
Genetic Engineering & Biotechnology News Cancer therapies often target cells that grow and divide rapidly, such as stem cells, but in studying how stomach cancers occur, researchers at Washington University School of Medicine in St. Louis found that even when the stomach can’t make stem cells … Stem Cell Banking Market Expected to Grow Rapidly with Size, Share, Demand and Revenue in International Market …Medgadget (blog) Mature cells also play role in initiating cancer, study suggestsNews-Medical.net Stem Cell Market Growth Analysis by Manufacturers, Market Status, And Competition Trend Forecast 2022Expert Herald ExpressObserver –MilTech all 14 news articles » |
WGRZ-TV |
Immunotherapy closing in on a cure for cancer
WGRZ-TV The immunotherapy trials are taking place in select cities across the United States, but people who live in Kentuckiana don’t have to travel far to get on the list. It’s happening right now at the James Graham Brown Cancer Center. James Long has spent … |